Author

Julien Rossignol

Centre National de la Recherche ScientifiqueORCID 0000-0003-3052-1424Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:differential expression· 1 Assay:proteomics· 1

Frequent Co-Authors

Michaël DussiotiD· 2 shared Olivier HermineiD· 2 shared Achille AoubaiD· 1 shared Alexandra Audemard‐VergeriD· 1 shared Alexis MathianiD· 1 shared Amélie Bigorgne· 1 shared Angélique Lebouvier· 1 shared Annalisa SantiniiD· 1 shared

Activity by Year

2025-2025 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 30 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Michaël DussiotORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Cancer BiologybioRxivPreprintNov 3, 2025

AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors in mastocytosis

Kitsada Kangboonruang, Philippe Drabent, Fatlinda Maksut…·Leïla Maouche-Chrétien

This study identifies AXL as a driver of mast cell survival and TKI resistance in mastocytosis and shows that dual KIT/AXL inhibition restores TKI sensitivity.

DOI 10.1101/2025.11.03.686205

humanproteomics

𝕏 PostBluesky

Cell BiologyBloodPeer-reviewedSep 19, 2025

VEXAS anemia is a mosaic erythroblastopenia

François Rodrigues, Giulia Hardouin, Sara El Hoss…·Jean‐David Bouaziz

This study investigates VEXAS anemia, showing that UBA1 mutations affect erythroblast differentiation but not mature red cells, leading to a mosaic erythroblastopenia.

9 citationstop 4%

humanbulk RNA-seq

𝕏 PostBluesky